{"id":112980,"date":"2026-09-21T18:26:10","date_gmt":"2026-09-21T16:26:10","guid":{"rendered":"https:\/\/canfali.com\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\/"},"modified":"2026-09-21T18:40:35","modified_gmt":"2026-09-21T16:40:35","slug":"hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer","status":"publish","type":"post","link":"https:\/\/canfali.com\/ca-es\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\/","title":{"rendered":"HCB Benidorm incorpora un biomarcador sanguini i prepara nous tractaments davant l\u2019Alzheimer"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">El diagn\u00f2stic i tractament de l\u2019Alzheimer afronten una nova etapa amb la incorporaci\u00f3 de biomarcadors sanguinis i ter\u00e0pies dirigides a mecanismes concrets de la malaltia. A HCB Benidorm, el Servei de Neurologia ja utilitza la determinaci\u00f3 de p-tau217 en determinats pacients i prepara el circuit assistencial necessari per a aplicar donanemab en casos seleccionats.<\/p>\n\n<p class=\"wp-block-paragraph\">L\u2019<strong>Alzheimer a HCB Benidorm<\/strong> comen\u00e7a a abordar-se amb eines que permeten anar m\u00e9s enll\u00e0 dels s\u00edmptomes. El Servei de Neurologia, integrat pels doctors Paul Vinueza i Jos\u00e9 Javier Hern\u00e1ndez, ja utilitza en determinats pacients la determinaci\u00f3 de <strong>p-tau217<\/strong>, un biomarcador sanguini relacionat amb canvis biol\u00f2gics associats a la malaltia.<\/p>\n\n<p class=\"wp-block-paragraph\">La prova es realitza mitjan\u00e7ant una extracci\u00f3 de sang i aporta informaci\u00f3 sobre processos vinculats a les prote\u00efnes amiloide i tau. No obstant aix\u00f2, els especialistes no la utilitzen de manera a\u00efllada: els resultats s\u2019interpreten junt amb la hist\u00f2ria cl\u00ednica, l\u2019exploraci\u00f3 m\u00e8dica, la valoraci\u00f3 neuropsicol\u00f2gica i, quan \u00e9s necessari, altres proves diagn\u00f2stiques.<\/p>\n\n<p class=\"wp-block-paragraph\">Segons explica el neur\u00f2leg Paul Vinueza, aquest tipus d\u2019an\u00e0lisi pot facilitar una identificaci\u00f3 m\u00e9s precisa de determinats casos i, en algunes situacions, reduir la necessitat de rec\u00f3rrer a proves m\u00e9s complexes.<\/p>\n\n<h2 id=\"h-un-nuevo-tratamiento-para-casos-seleccionados\" class=\"wp-block-heading\">Un nou tractament per a casos seleccionats<\/h2>\n\n<p class=\"wp-block-paragraph\"><p class=\"isSelectedEnd\">El canvi tamb\u00e9 arriba al tractament. El Servei de Neurologia d\u2019HCB Hospitales treballa en la <strong>protocol\u00b7litzaci\u00f3 de donanemab<\/strong>, un antic\u00f2s monoclonal dirigit contra les plaques de beta-amiloide i destinat a determinats pacients adults amb Alzheimer simptom\u00e0tic en fases inicials.<\/p><br\/>\u00a0<\/p>\n\n<p class=\"wp-block-paragraph\">Abans de plantejar aquest tractament, els especialistes han de confirmar la pres\u00e8ncia de patologia amiloide i comprovar que el pacient compleix els criteris cl\u00ednics i de seguretat establits. A m\u00e9s, la selecci\u00f3 t\u00e9 en compte diferents factors cl\u00ednics i gen\u00e8tics.<\/p>\n\n<p class=\"wp-block-paragraph\">Per tant, donanemab no representa una cura ni det\u00e9 completament la progressi\u00f3 de l\u2019Alzheimer. El seu objectiu \u00e9s actuar sobre un dels mecanismes biol\u00f2gics relacionats amb la malaltia, davant l\u2019enfocament dels tractaments que se centren principalment en el control dels s\u00edmptomes.<\/p>\n\n<p class=\"wp-block-paragraph\">L\u2019aplicaci\u00f3 d\u2019aquestes ter\u00e0pies tamb\u00e9 requereix un seguiment especialitzat. En particular, els pacients necessiten controls cl\u00ednics i proves d\u2019imatge pel risc de desenvolupar anomalies d\u2019imatge relacionades amb l\u2019amiloide (ARIA), entre altres possibles efectes adversos.<\/p>\n\n<p class=\"wp-block-paragraph\">Per aquest motiu, HCB Hospitales est\u00e0 organitzant un circuit que inclou la selecci\u00f3 de pacients, la confirmaci\u00f3 de la patologia, l\u2019administraci\u00f3 del tractament i el seguiment posterior.<\/p>\n\n<h2 id=\"h-el-diagnostico-temprano-gana-importancia\" class=\"wp-block-heading\">El diagn\u00f2stic preco\u00e7 guanya import\u00e0ncia<\/h2>\n\n<p class=\"wp-block-paragraph\">L\u2019arribada d\u2019aquests biomarcadors i tractaments est\u00e0 refor\u00e7ant l\u2019inter\u00e9s per identificar l\u2019Alzheimer en les seues primeres fases. L\u2019objectiu passa progressivament de valorar \u00fanicament les manifestacions cl\u00edniques a incorporar informaci\u00f3 sobre la biologia de la malaltia.<\/p>\n\n<p class=\"wp-block-paragraph\">En aquest context, Vinueza apunta a un futur en qu\u00e8 les an\u00e0lisis sangu\u00ednies com el p-tau217 tinguen una pres\u00e8ncia cada vegada major en la pr\u00e0ctica cl\u00ednica i permeten detectar determinats processos d\u2019una manera m\u00e9s accessible.<\/p>\n\n<p class=\"wp-block-paragraph\">A m\u00e9s, la investigaci\u00f3 continua amb altres l\u00ednies terap\u00e8utiques dirigides a prote\u00efnes com la tau o a processos relacionats amb la neuroinflamaci\u00f3.<\/p>\n\n<p class=\"wp-block-paragraph\">Els primers tractaments dirigits contra l\u2019amiloide han mostrat beneficis cl\u00ednics moderats, per la qual cosa els especialistes remarquen que encara no permeten parlar d\u2019una cura. No obstant aix\u00f2, representen un canvi en la manera d\u2019abordar una malaltia que durant anys s\u2019ha tractat principalment des del control dels seus s\u00edmptomes.<\/p>\n<div class=\"wp-block-post-author-name\">Carolina Mota<\/div>","protected":false},"excerpt":{"rendered":"El diagn\u00f2stic i tractament de l\u2019Alzheimer afronten una nova etapa amb la incorporaci\u00f3 de biomarcadors sanguinis i ter\u00e0pies&hellip;","protected":false},"author":18,"featured_media":112979,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"csco_display_header_overlay":false,"csco_singular_sidebar":"","csco_page_header_type":"","csco_page_load_nextpost":"","csco_post_video_location":[],"csco_post_video_location_hash":"","csco_post_video_url":"","csco_post_video_bg_start_time":0,"csco_post_video_bg_end_time":0,"footnotes":""},"categories":[576],"tags":[10200,10204,4757,10203,10202,2146,10201,872,10205],"poblacion":[],"class_list":["post-112980","post","type-post","status-publish","format-standard","has-post-thumbnail","category-salud-2","tag-alzheimer","tag-biomarcadors","tag-diagnostic","tag-donanemab","tag-hcb-benidorm","tag-neurologia-ca-es","tag-p-tau217","tag-salut","tag-tractaments","cs-entry","cs-video-wrap"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>HCB Benidorm incorpora un biomarcador sanguini i prepara nous tractaments davant l\u2019Alzheimer - Canfali<\/title>\n<meta name=\"description\" content=\"HCB Benidorm incorpora el biomarcador p-tau217 per a determinats pacients i prepara l\u2019aplicaci\u00f3 de donanemab en l\u2019Alzheimer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/canfali.com\/ca-es\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HCB Benidorm incorpora un biomarcador sanguini i prepara nous tractaments davant l\u2019Alzheimer\" \/>\n<meta property=\"og:description\" content=\"HCB Benidorm incorpora el biomarcador p-tau217 per a determinats pacients i prepara l\u2019aplicaci\u00f3 de donanemab en l\u2019Alzheimer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/canfali.com\/ca-es\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\/\" \/>\n<meta property=\"og:site_name\" content=\"Canfali\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/es-es.facebook.com\/CANFALIMarinaAlta\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-21T16:26:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-21T16:40:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/canfali.com\/app\/uploads\/2026\/09\/Alzheimer-en-HCB-Benidorm-1-1024x576.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Carolina Mota\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@canfalima\" \/>\n<meta name=\"twitter:site\" content=\"@canfalima\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Carolina Mota\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\\\/\"},\"author\":{\"name\":\"Carolina Mota\",\"@id\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/#\\\/schema\\\/person\\\/6769881c8113f5c26e8bcf61292908fc\"},\"headline\":\"HCB Benidorm incorpora un biomarcador sanguini i prepara nous tractaments davant l\u2019Alzheimer\",\"datePublished\":\"2026-09-21T16:26:10+00:00\",\"dateModified\":\"2026-09-21T16:40:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\\\/\"},\"wordCount\":604,\"publisher\":{\"@id\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/canfali.com\\\/app\\\/uploads\\\/2026\\\/09\\\/Alzheimer-en-HCB-Benidorm-1.png\",\"keywords\":[\"Alzheimer\",\"biomarcadors\",\"diagn\u00f2stic\",\"donanemab\",\"HCB Benidorm\",\"neurologia\",\"p-tau217\",\"salut\",\"tractaments\"],\"articleSection\":[\"Salud\"],\"inLanguage\":\"va-ES\",\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/canfali.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\\\/\",\"url\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\\\/\",\"name\":\"HCB Benidorm incorpora un biomarcador sanguini i prepara nous tractaments davant l\u2019Alzheimer - Canfali\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/canfali.com\\\/app\\\/uploads\\\/2026\\\/09\\\/Alzheimer-en-HCB-Benidorm-1.png\",\"datePublished\":\"2026-09-21T16:26:10+00:00\",\"dateModified\":\"2026-09-21T16:40:35+00:00\",\"description\":\"HCB Benidorm incorpora el biomarcador p-tau217 per a determinats pacients i prepara l\u2019aplicaci\u00f3 de donanemab en l\u2019Alzheimer.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\\\/#breadcrumb\"},\"inLanguage\":\"va-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/canfali.com\\\/ca-es\\\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"va-ES\",\"@id\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/canfali.com\\\/app\\\/uploads\\\/2026\\\/09\\\/Alzheimer-en-HCB-Benidorm-1.png\",\"contentUrl\":\"https:\\\/\\\/canfali.com\\\/app\\\/uploads\\\/2026\\\/09\\\/Alzheimer-en-HCB-Benidorm-1.png\",\"width\":1672,\"height\":941,\"caption\":\"Dr.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HCB Benidorm incorpora un biomarcador sanguini i prepara nous tractaments davant l\u2019Alzheimer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/#website\",\"url\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/\",\"name\":\"Canfali\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"va-ES\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/#organization\",\"name\":\"Canfali\",\"url\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"va-ES\",\"@id\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/canfali.com\\\/app\\\/uploads\\\/2025\\\/12\\\/canfali_marina_alta_logo.png\",\"contentUrl\":\"https:\\\/\\\/canfali.com\\\/app\\\/uploads\\\/2025\\\/12\\\/canfali_marina_alta_logo.png\",\"width\":225,\"height\":225,\"caption\":\"Canfali\"},\"image\":{\"@id\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/es-es.facebook.com\\\/CANFALIMarinaAlta\",\"https:\\\/\\\/x.com\\\/canfalima\",\"https:\\\/\\\/www.instagram.com\\\/canfalimarinaalta\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/#\\\/schema\\\/person\\\/6769881c8113f5c26e8bcf61292908fc\",\"name\":\"Carolina Mota\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"va-ES\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e81d86e4ab597755fbd9d599d59bfa33a6782c2145f947174ce7675a088f023a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e81d86e4ab597755fbd9d599d59bfa33a6782c2145f947174ce7675a088f023a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e81d86e4ab597755fbd9d599d59bfa33a6782c2145f947174ce7675a088f023a?s=96&d=mm&r=g\",\"caption\":\"Carolina Mota\"},\"url\":\"https:\\\/\\\/canfali.com\\\/ca-es\\\/author\\\/carolinamota\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"HCB Benidorm incorpora un biomarcador sanguini i prepara nous tractaments davant l\u2019Alzheimer - Canfali","description":"HCB Benidorm incorpora el biomarcador p-tau217 per a determinats pacients i prepara l\u2019aplicaci\u00f3 de donanemab en l\u2019Alzheimer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/canfali.com\/ca-es\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\/","og_locale":"en_US","og_type":"article","og_title":"HCB Benidorm incorpora un biomarcador sanguini i prepara nous tractaments davant l\u2019Alzheimer","og_description":"HCB Benidorm incorpora el biomarcador p-tau217 per a determinats pacients i prepara l\u2019aplicaci\u00f3 de donanemab en l\u2019Alzheimer.","og_url":"https:\/\/canfali.com\/ca-es\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\/","og_site_name":"Canfali","article_publisher":"https:\/\/es-es.facebook.com\/CANFALIMarinaAlta","article_published_time":"2026-09-21T16:26:10+00:00","article_modified_time":"2026-09-21T16:40:35+00:00","og_image":[{"width":1024,"height":576,"url":"https:\/\/canfali.com\/app\/uploads\/2026\/09\/Alzheimer-en-HCB-Benidorm-1-1024x576.png","type":"image\/png"}],"author":"Carolina Mota","twitter_card":"summary_large_image","twitter_creator":"@canfalima","twitter_site":"@canfalima","twitter_misc":{"Written by":"Carolina Mota","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/canfali.com\/ca-es\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\/#article","isPartOf":{"@id":"https:\/\/canfali.com\/ca-es\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\/"},"author":{"name":"Carolina Mota","@id":"https:\/\/canfali.com\/ca-es\/#\/schema\/person\/6769881c8113f5c26e8bcf61292908fc"},"headline":"HCB Benidorm incorpora un biomarcador sanguini i prepara nous tractaments davant l\u2019Alzheimer","datePublished":"2026-09-21T16:26:10+00:00","dateModified":"2026-09-21T16:40:35+00:00","mainEntityOfPage":{"@id":"https:\/\/canfali.com\/ca-es\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\/"},"wordCount":604,"publisher":{"@id":"https:\/\/canfali.com\/ca-es\/#organization"},"image":{"@id":"https:\/\/canfali.com\/ca-es\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\/#primaryimage"},"thumbnailUrl":"https:\/\/canfali.com\/app\/uploads\/2026\/09\/Alzheimer-en-HCB-Benidorm-1.png","keywords":["Alzheimer","biomarcadors","diagn\u00f2stic","donanemab","HCB Benidorm","neurologia","p-tau217","salut","tractaments"],"articleSection":["Salud"],"inLanguage":"va-ES","copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/canfali.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/canfali.com\/ca-es\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\/","url":"https:\/\/canfali.com\/ca-es\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\/","name":"HCB Benidorm incorpora un biomarcador sanguini i prepara nous tractaments davant l\u2019Alzheimer - Canfali","isPartOf":{"@id":"https:\/\/canfali.com\/ca-es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/canfali.com\/ca-es\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\/#primaryimage"},"image":{"@id":"https:\/\/canfali.com\/ca-es\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\/#primaryimage"},"thumbnailUrl":"https:\/\/canfali.com\/app\/uploads\/2026\/09\/Alzheimer-en-HCB-Benidorm-1.png","datePublished":"2026-09-21T16:26:10+00:00","dateModified":"2026-09-21T16:40:35+00:00","description":"HCB Benidorm incorpora el biomarcador p-tau217 per a determinats pacients i prepara l\u2019aplicaci\u00f3 de donanemab en l\u2019Alzheimer.","breadcrumb":{"@id":"https:\/\/canfali.com\/ca-es\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\/#breadcrumb"},"inLanguage":"va-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/canfali.com\/ca-es\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\/"]}]},{"@type":"ImageObject","inLanguage":"va-ES","@id":"https:\/\/canfali.com\/ca-es\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\/#primaryimage","url":"https:\/\/canfali.com\/app\/uploads\/2026\/09\/Alzheimer-en-HCB-Benidorm-1.png","contentUrl":"https:\/\/canfali.com\/app\/uploads\/2026\/09\/Alzheimer-en-HCB-Benidorm-1.png","width":1672,"height":941,"caption":"Dr."},{"@type":"BreadcrumbList","@id":"https:\/\/canfali.com\/ca-es\/hcb-benidorm-incorpora-un-biomarcador-sanguini-i-prepara-nous-tractaments-davant-lalzheimer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/canfali.com\/ca-es\/"},{"@type":"ListItem","position":2,"name":"HCB Benidorm incorpora un biomarcador sanguini i prepara nous tractaments davant l\u2019Alzheimer"}]},{"@type":"WebSite","@id":"https:\/\/canfali.com\/ca-es\/#website","url":"https:\/\/canfali.com\/ca-es\/","name":"Canfali","description":"","publisher":{"@id":"https:\/\/canfali.com\/ca-es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/canfali.com\/ca-es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"va-ES"},{"@type":"Organization","@id":"https:\/\/canfali.com\/ca-es\/#organization","name":"Canfali","url":"https:\/\/canfali.com\/ca-es\/","logo":{"@type":"ImageObject","inLanguage":"va-ES","@id":"https:\/\/canfali.com\/ca-es\/#\/schema\/logo\/image\/","url":"https:\/\/canfali.com\/app\/uploads\/2025\/12\/canfali_marina_alta_logo.png","contentUrl":"https:\/\/canfali.com\/app\/uploads\/2025\/12\/canfali_marina_alta_logo.png","width":225,"height":225,"caption":"Canfali"},"image":{"@id":"https:\/\/canfali.com\/ca-es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/es-es.facebook.com\/CANFALIMarinaAlta","https:\/\/x.com\/canfalima","https:\/\/www.instagram.com\/canfalimarinaalta\/"]},{"@type":"Person","@id":"https:\/\/canfali.com\/ca-es\/#\/schema\/person\/6769881c8113f5c26e8bcf61292908fc","name":"Carolina Mota","image":{"@type":"ImageObject","inLanguage":"va-ES","@id":"https:\/\/secure.gravatar.com\/avatar\/e81d86e4ab597755fbd9d599d59bfa33a6782c2145f947174ce7675a088f023a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e81d86e4ab597755fbd9d599d59bfa33a6782c2145f947174ce7675a088f023a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e81d86e4ab597755fbd9d599d59bfa33a6782c2145f947174ce7675a088f023a?s=96&d=mm&r=g","caption":"Carolina Mota"},"url":"https:\/\/canfali.com\/ca-es\/author\/carolinamota\/"}]}},"_links":{"self":[{"href":"https:\/\/canfali.com\/ca-es\/wp-json\/wp\/v2\/posts\/112980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canfali.com\/ca-es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canfali.com\/ca-es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canfali.com\/ca-es\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/canfali.com\/ca-es\/wp-json\/wp\/v2\/comments?post=112980"}],"version-history":[{"count":1,"href":"https:\/\/canfali.com\/ca-es\/wp-json\/wp\/v2\/posts\/112980\/revisions"}],"predecessor-version":[{"id":112981,"href":"https:\/\/canfali.com\/ca-es\/wp-json\/wp\/v2\/posts\/112980\/revisions\/112981"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canfali.com\/ca-es\/wp-json\/wp\/v2\/media\/112979"}],"wp:attachment":[{"href":"https:\/\/canfali.com\/ca-es\/wp-json\/wp\/v2\/media?parent=112980"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canfali.com\/ca-es\/wp-json\/wp\/v2\/categories?post=112980"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canfali.com\/ca-es\/wp-json\/wp\/v2\/tags?post=112980"},{"taxonomy":"poblacion","embeddable":true,"href":"https:\/\/canfali.com\/ca-es\/wp-json\/wp\/v2\/poblacion?post=112980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}